Current portfolio

Egle Therapeutics

Egle is developing a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Treg starving

  • Sector
    Healthcare
  • Country
    France
  • Fund
    LSP 7
  • Entry
    2021
  • Web
Logo
0
EQT logo